Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
CC transcript
Asset disposition
|
|
Cyclacel Pharmaceuticals, Inc. (CYCC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2022 |
SC 13G
| Dellora Investments LP reports a 5.2% stake in Cyclacel Pharmaceuticals, Inc. |
| 03/18/2021 |
SC 13G
| SPHERA FUNDS MANAGEMENT LTD. reports a 6.3% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/08/2021 |
SC 13G
| Ikarian Capital, LLC reports a 8.2% stake in Cyclacel Pharmaceuticals, Inc. |
| 12/28/2020 |
SC 13G
| PURA VIDA INVESTMENTS, LLC reports a 8.9% stake in Cyclacel Pharmaceuticals, Inc. |
| 12/23/2020 |
SC 13G
| Aspire Capital Fund, LLC reports a 5% stake in Cyclacel Pharmaceuticals, Inc. |
| 04/30/2020 |
SC 13G
| CVI Investments, Inc. reports a 9.9% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/12/2020 |
SC 13G
| RENAISSANCE TECHNOLOGIES LLC reports a 7.4% stake in CYCLACEL PHARMACEUTICALS, INC. |
| 02/02/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/19/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 05/28/2013 |
SC 13G
| Eastern Capital LTD reports a 7.1% stake in CYCLACEL PHARMACEUTICALS, INC. |
| 01/02/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/10/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/18/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 01/12/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|